These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4557796)

  • 41. The induction of vascular renal allograft rejection by leukocyte sensitizatin.
    Matthew TH; Lewers DT; Hogan GP; Rubio-Paez D; Alter HJ; Antonovych T; Bauer H; Maher JF; Schreiner GE
    J Lab Clin Med; 1971 Mar; 77(3):396-409. PubMed ID: 4928752
    [No Abstract]   [Full Text] [Related]  

  • 42. Functional recovery from acute rejection as a guide to ultimate renal graft survival.
    Silcott GR; Barbour BH; Mendez R; Bischel MD; Berne TV
    Arch Surg; 1972 Jun; 104(6):791-3. PubMed ID: 4555178
    [No Abstract]   [Full Text] [Related]  

  • 43. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 44. Cadaveric kidney transplantation in a patient with donor-specific antileukocyte cytotoxic antibodies. Report of a case.
    Patel R; Wilson RE; Birtch AG; Merrill JP; Murray JE; Busch G
    Transplantation; 1971 Jul; 12(1):88-91. PubMed ID: 4932701
    [No Abstract]   [Full Text] [Related]  

  • 45. Renal transplantation between 33 HL-A-identical siblings.
    Descamps B; Hinglais N; Crosnier J
    Transplant Proc; 1973 Mar; 5(1):231-6. PubMed ID: 4266652
    [No Abstract]   [Full Text] [Related]  

  • 46. The correlation of mixed leukocyte culture responses with kidney allograft survival.
    Sullivan CE; Stevens LE; Main RK; Jones MJ; Reemtsma K
    Transplantation; 1971 Feb; 11(2):190-1. PubMed ID: 4931241
    [No Abstract]   [Full Text] [Related]  

  • 47. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 48. A trial with heterologous antilymphocyte globulin in man.
    Starzl TE; Brettschneider L; Penn I; Schmidt RW; Bell P; Kashiwagi N; Townsend CM; Putnam CW
    Transplant Proc; 1969 Mar; 1(1):448-54. PubMed ID: 4944259
    [No Abstract]   [Full Text] [Related]  

  • 49. Heterophil antibodies in the sera of recipients in clinical renal transplantation.
    O'Kane HO; Shorter RG; Nava C; Hallenbeck GA
    Surgery; 1969 Oct; 66(4):682-6. PubMed ID: 4898465
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients.
    Hulme B; Kenyon JR; Owen K; Snell M; Mowbray JF; Porter KA; Starkie SJ; Muras H; Peart WS
    Arch Dis Child; 1972 Aug; 47(254):486-94. PubMed ID: 4558383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mixed leukocyte response in human renal transplantation.
    Shons AR; Etheredge EE; Schmidtke JR; Najarian JS
    Transplant Proc; 1973 Mar; 5(1):337-42. PubMed ID: 4266657
    [No Abstract]   [Full Text] [Related]  

  • 53. Proliferation of white blood cells in the blood of human renal allograft recipients. Lack of correlation with acute rejection episodes.
    Häyry P; Lalla M; Pasternack A; Virolainen M
    Ann Clin Res; 1972 Apr; 4(2):100-9. PubMed ID: 4554943
    [No Abstract]   [Full Text] [Related]  

  • 54. Reliability of the changes of serum complement, C3, and immunoglobulins during acute rejection of renal allografts: correlations with clinical severity.
    Rodriguez-Iturbe B; Serrano H; García R; Gallegos B
    Transplantation; 1971 Nov; 12(5):405-7. PubMed ID: 4114304
    [No Abstract]   [Full Text] [Related]  

  • 55. Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation.
    Seigler HF; Gunnells JC; Robinson RR; Ward FE; Amos DB; Rowlands DT; Burkholder PM; Klein WJ; Stickel DL
    J Clin Invest; 1972 Dec; 51(12):3200-15. PubMed ID: 4565678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs.
    Legrain M; Gandjbakhch ; Dubois M; Wajcner G; Rottembourg J; Guilmet D
    Transplant Proc; 1969 Mar; 1(1):293-5. PubMed ID: 4944230
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical use of antilymphoblast serum.
    Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 59. Pancreas rejection in combined pancreaticoduodenal and renal allotransplantation in man.
    Largiader F; Uhlschmid G; Binswanger U; Zaruba K
    Transplantation; 1975 Feb; 19(2):185-7. PubMed ID: 1091042
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.